Pianko, Stephen <br/><br/>
Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial.  [electronic resource] 

 -  Annals of internal medicine  Dec 2015 
 - 809-17 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1539-3704 
<br/><br/><label>Standard No.: </label>10.7326/M15-1014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--adverse effects<br/>Carbamates--adverse effects<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--complications<br/>Heterocyclic Compounds, 4 or More Rings--adverse effects<br/>Humans<br/>Liver Cirrhosis--complications<br/>Male<br/>Middle Aged<br/>RNA, Viral--blood<br/>Ribavirin--adverse effects<br/>Sofosbuvir--adverse effects<br/>Treatment Outcome<br/>Young Adult